Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The BCL2 major breakpoint region (mbr) regulates gene expression

Abstract

BCL2 expression is finely tuned by a variety of environmental and endogenous stimuli and regulated at both transcriptional and post-transcriptional levels. Our previous investigations demonstrated that the BCL2 major breakpoint region (mbr) in the 3′-UTR upregulates reporter gene expression, which implies that this region possessed intrinsic regulatory function. However, the effect of the mbr on BCL2 expression, and the underlying regulatory mechanisms, remain to be elucidated. To assess the direct effect of the mbr on the transcriptional activity of the BCL2 gene, we employed targeted homologous recombination to establish a mbr+/mbr heterozygous Nalm-6 cell line and then compared the transcriptional activity and apoptotic effect on transcription between the wild type and targeted alleles. We found that deletion of the mbr significantly decreased the transcriptional activity of the corresponding allele in the mbr+/mbr cell. The BCL2 allele deleted of the mbr had a slower response to apoptotic stimuli than did the wild type allele. The regulatory function of the mbr was mediated through SATB1. Overexpression of SATB1 increased BCL2 expression, while knockdown of SATB1 with RNAi decreased BCL2 expression. Our results clearly indicated that the mbr could positively regulate BCL2 gene expression and this regulatory function was closely related to SATB1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Abbreviations

mbr:

major breakpoint region

SATB1:

special AT-rich sequence-binding protein 1

MAR:

matrix attachment region

CRE:

cAMP responsive element

NF-κB:

nuclear factor-kappa B

UTR:

untranslated region

EMSA:

electrophoretic mobility shift assay

DT:

diphtheria-toxin

References

  • Adams JM, Huang DC, Puthalakath H, Bouillet P, Vairo G, Moriishi K et al. (1999). Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins. Cold Spring Harb Symp Quant Biol 64: 351–358.

    Article  CAS  PubMed  Google Scholar 

  • Alvarez JD, Yasui DH, Niida H, Joh T, Loh DY, Kohwi-Shigematsu T . (2000). The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev 14: 521–535.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chen DF, Schneider GE, Martinou JC, Tonegawa S . (1997). Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385: 434–439.

    Article  CAS  PubMed  Google Scholar 

  • Chen HM, Boxer LM . (1995). Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells. Mol Cell Biol 15: 3840–3847.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen M, Quintans J, Fuks Z, Thompson C, Kufe DW, Weichselbaum RR . (1995). Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide. Cancer Res 55: 991–994.

    CAS  PubMed  Google Scholar 

  • Delic J, Onclercq R, Moisan-Coppey M . (1991). Inhibition and enhancement of eukaryotic gene expression by potential non-B DNA sequences. Biochem Biophys Res Commun 181: 818–826.

    Article  CAS  PubMed  Google Scholar 

  • Dickinson LA, Joh T, Kohwi Y, Kohwi-Shigematsu T . (1992). A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell 70: 631–645.

    Article  CAS  PubMed  Google Scholar 

  • DiCroce PA, Krontiris TG . (1995). The BCL2 major breakpoint region is a sequence- and cell-cycle-specific binding site of the Ku antigen. Proc Natl Acad Sci USA 92: 10137–10141.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Donnini M, Lapucci A, Papucci L, Witort E, Jacquier A, Brewer G et al. (2004). Identification of TINO: a new evolutionarily conserved BCL-2 AU-rich element RNA-binding protein. J Biol Chem 279: 20154–20166.

    Article  CAS  PubMed  Google Scholar 

  • Grawunder U, Zimmer D, Fugmann S, Schwarz K, Lieber MR . (1998). DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes. Mol Cell 2: 477–484.

    Article  CAS  PubMed  Google Scholar 

  • Grigoriev M, Praseuth D, Robin P, Hemar A, Saison-Behmoaras T, Dautry-Varsat A et al. (1992). A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF kappa B binding to interleukin-2 receptor alpha-regulatory sequence. J Biol Chem 267: 3389–3395.

    CAS  PubMed  Google Scholar 

  • Heckman CA, Mehew JW, Boxer LM . (2002). NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells. Oncogene 21: 3898–3908.

    Article  CAS  PubMed  Google Scholar 

  • Heckman CA, Mehew JW, Ying GG, Introna M, Golay J, Boxer LM . (2000). A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells. J Biol Chem 275: 6499–6508.

    Article  CAS  PubMed  Google Scholar 

  • Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ . (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334–336.

    Article  CAS  PubMed  Google Scholar 

  • Kato M, Shimizu N . (1992). Effect of the potential triplex DNA region on the in vitro expression of bacterial beta-lactamase gene in superhelical recombinant plasmids. J Biochem (Tokyo) 112: 492–494.

    Article  CAS  Google Scholar 

  • Kohwi Y, Kohwi-Shigematsu T . (1991). Altered gene expression correlates with DNA structure. Genes Dev 5: 2547–2554.

    Article  CAS  PubMed  Google Scholar 

  • Lang G, Gombert WM, Gould HJ . (2005). A transcriptional regulatory element in the coding sequence of the human Bcl-2 gene. Immunology 114: 25–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miyashita T, Harigai M, Hanada M, Reed JC . (1994). Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54: 3131–3135.

    CAS  PubMed  Google Scholar 

  • Narla RK, Dong Y, Uckun FM . (2001). Apoptosis inducing novel anti-leukemic agent, bis(4,7-dimethyl-1,10 phenanthroline) sulfatooxovanadium(IV) [VO(SO4)(Me2-Phen)2] depolarizes mitochondrial membranes. Leuk Lymphoma 41: 625–634.

    Article  CAS  PubMed  Google Scholar 

  • Patrone G, Puppo F, Cusano R, Scaranari M, Ceccherini I, Puliti A et al. (2000). Nuclear run-on assay using biotin labeling, magnetic bead capture and analysis by fluorescence-based RT-PCR. Biotechniques 29: 1012–1014, 1016–1017.

    Article  CAS  PubMed  Google Scholar 

  • Perillo B, Sasso A, Abbondanza C, Palumbo G . (2000). 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20: 2890–2901.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Raghavan SC, Chastain P, Lee JS, Hegde BG, Houston S, Langen R et al. (2005). Evidence for a triplex DNA conformation at the bcl-2 major breakpoint region of the t(14;18) translocation. J Biol Chem 280: 22749–22760.

    Article  CAS  PubMed  Google Scholar 

  • Ramakrishnan M, Liu WM, DiCroce PA, Posner A, Zheng J, Kohwi-Shigematsu T et al. (2000). Modulated binding of SATB1, a matrix attachment region protein, to the AT-rich sequence flanking the major breakpoint region of BCL2. Mol Cell Biol 20: 868–877.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sato N, Hotta K, Waguri S, Nitatori T, Tohyama K, Tsujimoto Y et al. (1994). Neuronal differentiation of PC12 cells as a result of prevention of cell death by bcl-2. J Neurobiol 25: 1227–1234.

    Article  CAS  PubMed  Google Scholar 

  • Schiavone N, Rosini P, Quattrone A, Donnini M, Lapucci A, Citti L et al. (2000). A conserved AU-rich element in the 3′-untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis. FASEB J 14: 174–184.

    Article  CAS  PubMed  Google Scholar 

  • Sun Y, Wang T, Su Y, Yin Y, Xu S, Ma C, Han X . (2006). The behavior of SATB1, a MAR-binding protein, in response to apoptosis stimulation. Cell Biol Int 30: 244–247.

    Article  CAS  PubMed  Google Scholar 

  • Suzuki A, Matsuzawa A, Iguchi T . (1996). Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract. Oncogene 13: 31–37.

    CAS  PubMed  Google Scholar 

  • Tong X, Yin L, Joshi S, Rosenberg DW, Giardina C . (2005). Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors. J Biol Chem 280: 15503–15509.

    Article  CAS  PubMed  Google Scholar 

  • Tsurusawa M, Saeki K, Fujimoto T . (1997). Differential induction of apoptosis on human lymphoblastic leukemia Nalm-6 and Molt-4 cells by various antitumor drugs. Int J Hematol 66: 79–88.

    Article  CAS  PubMed  Google Scholar 

  • van Holde K, Zlatanova J . (1994). Unusual DNA structures, chromatin and transcription. Bioessays 16: 59–68.

    Article  CAS  PubMed  Google Scholar 

  • Wilson BE, Mochon E, Boxer LM . (1996). Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol 16: 5546–5556.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM . (2001). Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene 20: 240–251.

    Article  CAS  PubMed  Google Scholar 

  • Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T . (2002). SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419: 641–645.

    Article  CAS  PubMed  Google Scholar 

  • Young RL, Korsmeyer SJ . (1993). A negative regulatory element in the bcl-2 5′-untranslated region inhibits expression from an upstream promoter. Mol Cell Biol 13: 3686–3697.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang J, Ma C, Han X, Durrin LK, Sun Y . (2006). The bcl-2 major breakpoint region (mbr) possesses transcriptional regulatory function. Gene 379: 127–131.

    Article  CAS  PubMed  Google Scholar 

  • Zhang MX, Ou H, Shen YH, Wang J, Wang J, Coselli J et al. (2005). Regulation of endothelial nitric oxide synthase by small RNA. Proc Natl Acad Sci USA 102: 16967–16972.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Dr Krontiris for his kind help in this work. This work was supported by grants from the National Natural Science Foundation of China (30371592), the Nature Science Foundation of Jiangsu Province (BK2003003), the Special Funds for Major State Basic Research Program of China (973 Program, 2006CB503908) and Opening Foundation from Jiangsu key laboratory for molecular and medical biotechnology.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to X Han or Y Sun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ma, C., Zhang, J., Durrin, L. et al. The BCL2 major breakpoint region (mbr) regulates gene expression. Oncogene 26, 2649–2657 (2007). https://doi.org/10.1038/sj.onc.1210069

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210069

Keywords

This article is cited by

Search

Quick links